Xiamen Amoytop Biotech Co. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003RT3
CNY
81.57
8.01 (10.89%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,803.42
2,089.09
1,519.06
1,126.51
789.96
726.00
445.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,803.42
2,089.09
1,519.06
1,126.51
789.96
726.00
445.90
Raw Material Cost
198.45
150.94
177.97
132.07
89.69
86.09
61.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.65
0.78
0.87
1.29
2.69
8.51
8.42
Selling and Distribution Expenses
1,383.82
1,051.44
834.61
693.50
497.52
482.12
316.42
Other Expenses
28.73
22.50
14.49
7.68
6.99
4.05
2.83
Total Expenditure (Excl Depreciation)
1,870.25
1,428.12
1,158.40
903.63
659.81
617.20
414.39
Operating Profit (PBDIT) excl Other Income
933.1999999999999
661
360.7
222.89999999999998
130.2
108.80000000000001
31.5
Other Income
0.79
-7.94
-3.47
-6.67
10.40
-9.16
-8.00
Operating Profit (PBDIT)
1,024.24
719.77
406.77
259.10
179.03
137.43
60.53
Interest
0.65
0.78
0.87
1.29
2.69
8.51
8.42
Exceptional Items
0.88
-10.11
0.40
1.80
1.53
0.02
0.11
Gross Profit (PBDT)
2,604.97
1,938.15
1,341.09
994.44
700.28
639.91
384.62
Depreciation
93.45
68.22
50.38
44.33
38.80
37.93
37.95
Profit Before Tax
931.03
640.65
355.93
215.29
139.07
91.01
14.27
Tax
103.42
85.21
68.91
34.09
22.50
26.72
-1.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
827.60
555.45
287.02
181.20
116.57
64.29
16.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
827.60
555.45
287.02
181.20
116.57
64.29
16.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
827.60
555.45
287.02
181.20
116.57
64.29
16.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,553.32
1,876.40
1,407.60
1,161.26
1,000.40
563.55
499.26
Earnings per share (EPS)
2.03
1.37
0.71
0.45
0.29
0.16
0.04
Diluted Earnings per share
2.03
1.37
0.71
0.45
0.29
0.16
0.04
Operating Profit Margin (Excl OI)
33.17%
31.57%
23.69%
19.66%
16.43%
14.97%
6.86%
Gross Profit Margin
36.54%
33.93%
26.75%
23.05%
22.52%
17.76%
11.71%
PAT Margin
29.52%
26.59%
18.89%
16.09%
14.76%
8.86%
3.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 34.19% vs 37.52% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 49.01% vs 93.52% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 40.63% vs 77.40% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -25.00% vs -11.11% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Xiamen Amoytop Biotech Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,803.42
0
2,803.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,803.42
0
2,803.42
Raw Material Cost
198.45
0
198.45
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.65
0
0.65
Selling and Distribution Expenses
1,383.82
0
1,383.82
Other Expenses
28.73
0.00
28.73
Total Expenditure (Excl Depreciation)
1,870.25
0
1,870.25
Operating Profit (PBDIT) excl Other Income
933.18
0.00
933.18
Other Income
0.79
0
0.79
Operating Profit (PBDIT)
1,024.24
0
1,024.24
Interest
0.65
0
0.65
Exceptional Items
0.88
0
0.88
Gross Profit (PBDT)
2,604.97
0
2,604.97
Depreciation
93.45
0
93.45
Profit Before Tax
931.03
0
931.03
Tax
103.42
0
103.42
Provisions and contingencies
0
0
0.00
Profit After Tax
827.60
0
827.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
827.60
0
827.60
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
827.60
0
827.60
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,553.32
0
2,553.32
Earnings per share (EPS)
2.03
0
2.03
Diluted Earnings per share
2.03
0
2.03
Operating Profit Margin (Excl OI)
33.17%
0%
0.00
33.17%
Gross Profit Margin
36.54%
0%
0.00
36.54%
PAT Margin
29.52%
0%
0.00
29.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 280.34 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 34.19% vs 37.52% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 82.76 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 49.01% vs 93.52% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 102.34 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.63% vs 77.40% in Dec 2023

Annual - Interest
Interest 0.06 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -25.00% vs -11.11% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.17%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023